AZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
AZN GlobeNewsWire — February 10, 2025NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against AstraZeneca PLC (“AstraZeneca” or “the Company”) (NASDAQ: AZN) and certain of its officers.

Palatin to Report Second Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on February 13, 2025 — Neutral
PTN PRNewsWire — February 10, 2025CRANBURY, N.J. , Feb. 10, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its second quarter fiscal year 2025 operating results on Thursday, February 13, 2025, before the open of the U.S. financial markets.

MODV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ModivCare, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
MODV GlobeNewsWire — February 10, 2025NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ModivCare, Inc. (“ModivCare” or “the Company”) (NASDAQ: MODV) and certain of its officers.

REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit — Neutral
REGN PRNewsWire — February 10, 2025NEW YORK , Feb. 10, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, both dates inclusive (the "Class Period"), of the important March 10, 2025 lead plaintiff deadline. So what: If you purchased Regeneron securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

MGPI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MGP Ingredients, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
MGPI GlobeNewsWire — February 10, 2025NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against MGP Ingredients, Inc. (“MGP Ingredients” or “the Company”) (NASDAQ: MGPI) and certain of its officers.

IAS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Integral Ad Science Holding Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
IAS GlobeNewsWire — February 10, 2025NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Integral Ad Science Holding Corp. (“IAS” or “the Company”) (NASDAQ: IAS) and certain of its officers.

GO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Grocery Outlet Holding Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
GO GlobeNewsWire — February 10, 2025NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Grocery Outlet Holding Corp. (“Grocery Outlet” or “the Company”) (NASDAQ: GO) and certain of its officers.

EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
EPIX GlobeNewsWire — February 10, 2025NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ESSA Pharma Inc. (“ESSA” or “the Company”) (NASDAQ: EPIX) and certain of its officers.

Inventiva reports preliminary 2024 fiscal year financial results¹ and provides a business update — Neutral
IVA GlobeNewsWire — February 10, 2025Daix (France), New York City (New York, United States), February 10, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), and other diseases with significant unmet medical needs, today reported certain preliminary unaudited financial results for the full year ended December 31, 2024, including cash, cash equivalents, and revenues, and also provided a business update.

TELUS International (Cda) Inc. Class Action: Levi & Korsinsky Reminds TELUS International Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 31, 2025 - TIXT — Neutral
TIXT Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your TELUS International (Cda) Inc. (NYSE:TIXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/telus-international-lawsuit-submission-form?prid=128486&wire=1 or contact Joseph E. Levi, Esq.

Lost Money on Crocs, Inc. (CROX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky — Neutral
CROX Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Crocs, Inc. (NASDAQ:CROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/crocs-inc-lawsuit-submission-form?prid=128495&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in Monolithic Power Systems Inc. Lawsuit - MPWR — Neutral
MPWR Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Monolithic Power Systems Inc. (NASDAQ:MPWR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/monolithic-lawsuit-submission-form?prid=128497&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Reminds Nextracker Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 25, 2025 - NXT — Neutral
NXT Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Nextracker Inc. (NASDAQ:NXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nextracker-inc-lawsuit-submission-form?prid=128490&wire=1 or contact Joseph E. Levi, Esq.

Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - REGN — Neutral
REGN Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=128494&wire=1 or contact Joseph E. Levi, Esq.

CDLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cardlytics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
CDLX GlobeNewsWire — February 10, 2025NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cardlytics, Inc. (“Cardlytics” or “the Company”) (NASDAQ: CDLX) and certain of its officers.

APLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
APLT GlobeNewsWire — February 10, 2025NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT) and certain of its officers.

Napco Security Technologies, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Napco Security Technologies, Inc. (NSSC) — Neutral
NSSC Accesswire — February 10, 2025NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Napco Security Technologies, Inc. ("Napco Security Technologies, Inc.") (NASDAQ:NSSC) concerning possible violations of federal securities laws. On February 3, 2025, news website Investing.com published an article entitled "NAPCO Security stock tumbles after Q2 sales decline.

Wabtec Corporation Appoints Juan Perez to the Board of Directors — Neutral
WAB Business Wire — February 10, 2025PITTSBURGH--(BUSINESS WIRE)--Wabtec Corporation (NYSE: WAB) announced the appointment of Juan Perez to its Board of Directors, effective January 29, 2025. Mr. Perez also will be a nominee for election at Wabtec's annual meeting of stockholders in May 2025. Perez has extensive experience in information technology and corporate digital strategy as the Executive Vice President and Chief Information Officer for Salesforce. Prior to joining Salesforce in 2022, he was CIO and Engineering Officer for.

SAVA Deadline Today: SAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit — Neutral
SAVA PRNewsWire — February 10, 2025NEW YORK , Feb. 10, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Cassava Sciences, Inc. (NASDAQ: SAVA) between February 7, 2024 and November 24, 2024, both dates inclusive (the "Class Period"), of the important February 10, 2025 lead plaintiff deadline. So what: If you purchased Cassava securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Sell McDonald's on Monday's gains, Main Street Research investor says — Negative
MCD CNBC — February 10, 2025Main Street Research's James Demmert says to sell McDonald's and Charles Schwab. The investor is bullish on German software stock SAP.
